who created tirzepatide Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond Tirzepatide: A novel obesity drug

This dual-action medication, paired with expert guidance, makes achieving sustainable weight loss within your reach

Tirzepatide is a dual GLP-1 and GIP receptor agonist, which is part of why SURMOUNT-1 participants lost more weight on average than STEP 1 participants lost on semaglutide, though the two trials were not run head-to-head in the same population

Absorption speed and timing Proteins enter your bloodstream at different speeds, which makes timing a vital part of choosing supplements

However, do not combine Victoza with other GLP-1 agonists, such as Ozempic (semaglutide), Mounjaro (tirzepatide), or Trulicity (dulaglutide)